Gene editing revolutionizes molecular biology, enabling precise DNA modifications for research and potential therapies. However, it raises significant ethical questions about altering genetic code in living organisms, requiring careful consideration of risks and benefits.
, base editing, and prime editing are key techniques in gene editing. Each method offers unique advantages for modifying genes, expanding possibilities in research while also presenting ethical challenges that must be addressed in computational molecular biology.
Fundamentals of gene editing
Gene editing revolutionizes molecular biology by allowing precise modifications to DNA sequences
Enables researchers to study gene function, develop disease models, and explore potential therapeutic applications
Raises significant ethical questions about altering the genetic code of living organisms
CRISPR-Cas9 system
Top images from around the web for CRISPR-Cas9 system
Frontiers | CRISPR/Cas9: A Novel Weapon in the Arsenal to Combat Plant Diseases View original
Is this image relevant?
Frontiers | Gene Editing and Crop Improvement Using CRISPR-Cas9 System View original
Is this image relevant?
Frontiers | Principles, Applications, and Biosafety of Plant Genome Editing Using CRISPR-Cas9 View original
Is this image relevant?
Frontiers | CRISPR/Cas9: A Novel Weapon in the Arsenal to Combat Plant Diseases View original
Is this image relevant?
Frontiers | Gene Editing and Crop Improvement Using CRISPR-Cas9 System View original
Is this image relevant?
1 of 3
Top images from around the web for CRISPR-Cas9 system
Frontiers | CRISPR/Cas9: A Novel Weapon in the Arsenal to Combat Plant Diseases View original
Is this image relevant?
Frontiers | Gene Editing and Crop Improvement Using CRISPR-Cas9 System View original
Is this image relevant?
Frontiers | Principles, Applications, and Biosafety of Plant Genome Editing Using CRISPR-Cas9 View original
Is this image relevant?
Frontiers | CRISPR/Cas9: A Novel Weapon in the Arsenal to Combat Plant Diseases View original
Is this image relevant?
Frontiers | Gene Editing and Crop Improvement Using CRISPR-Cas9 System View original
Is this image relevant?
1 of 3
Utilizes guide RNA to direct Cas9 enzyme for targeted DNA cleavage
Enables precise gene knockout, insertion, or modification
Derived from bacterial adaptive immune system
Offers advantages of simplicity, efficiency, and versatility compared to earlier gene editing methods
Applied in various fields (agriculture, medicine, biotechnology)
Base editing techniques
Modifies individual DNA bases without double-strand breaks
Employs fusion proteins combining Cas9 and deaminase enzymes
Allows for specific C-to-T or A-to-G conversions
Reduces risk of unintended insertions or deletions
Useful for correcting point mutations associated with genetic disorders
Prime editing methods
Combines Cas9 nickase with reverse transcriptase
Uses prime editing guide RNA (pegRNA) to specify both target site and desired edit
Enables all types of gene edits (insertions, deletions, all base-to-base conversions)
Offers greater precision and reduced compared to traditional CRISPR
Expands the scope of genetic modifications possible in molecular biology research
Ethical considerations
Ethical implications of gene editing form a crucial aspect of computational molecular biology
Researchers must navigate complex moral and societal issues when developing and applying gene editing technologies
Balancing potential benefits with risks and ethical concerns shapes the future of genetic research
Germline vs somatic modifications
alter genes in reproductive cells or embryos
Changes pass to future generations
Raises concerns about altering human evolution
target non-reproductive cells
Effects limited to treated individual
Generally considered less ethically controversial
Debate centers on permissibility and regulation of germline editing
Considerations include long-term consequences and of future generations
Off-target effects
Unintended edits at non-target genomic sites
Can lead to mutations, chromosomal rearrangements, or altered gene expression
Pose risks of unforeseen health consequences in treated organisms
Necessitate development of improved specificity in gene editing tools
Require thorough screening and validation processes in research and clinical applications
Unintended consequences
Potential for ecological disruption when editing genes in plants or animals
Risk of creating new pathogens or altering existing ones unintentionally
Possibility of unexpected interactions between edited genes and other genetic or environmental factors
Challenges in predicting long-term effects of genetic modifications on complex biological systems
Emphasizes need for careful and monitoring in gene editing research
Regulatory landscape
Regulatory frameworks for gene editing vary globally, impacting research and applications
Balancing innovation with safety and ethical concerns shapes policy development
Computational molecular biologists must navigate complex regulatory environments
International guidelines
Emphasizes human dignity and
Provides global standards for governance and oversight
Addresses transboundary movement of genetically modified organisms
Varying levels of adoption and enforcement across countries
Aim to promote responsible research while addressing ethical concerns
National policies
United States: FDA regulates gene therapy; NIH oversees research ethics
European Union: Strict regulations on GMOs and gene editing in agriculture
China: Rapid advancement in gene editing research with evolving regulatory framework
Japan: Allows gene editing in food products with specific labeling requirements
Differences in policies create challenges for international collaboration and market access
Ongoing debates on appropriate level of regulation vs. scientific freedom
Research ethics committees
in the United States
in the United Kingdom
in Australia
Evaluate proposed gene editing studies for ethical compliance
Consider risks, benefits, and participant protections
Ensure adherence to national and international guidelines
Play crucial role in maintaining public trust in scientific research
Societal impacts
Gene editing technologies have far-reaching implications for society beyond the laboratory
Computational molecular biologists must consider broader societal context of their work
Ethical debates surrounding gene editing shape public perception and policy decisions
Enhancement vs therapy debate
Therapy aims to treat or prevent disease and disability
Enhancement seeks to improve traits beyond normal human function
(intelligence, physical abilities, longevity)
Blurred lines between therapy and enhancement in some cases
(preventing age-related cognitive decline)
Concerns about creating unfair advantages or exacerbating social inequalities
Philosophical questions about the nature of human identity and value
Accessibility and equity issues
High costs of gene editing treatments may limit access to wealthy individuals or nations
Potential to widen health disparities between socioeconomic groups
Concerns about "genetic divide" similar to digital divide
Debates on whether gene editing should be covered by health insurance or public healthcare systems
Ethical obligation to ensure equitable distribution of benefits from gene editing research
Cultural and religious perspectives
Varying attitudes towards gene editing across different cultures and religions
Some view it as "playing God" or interfering with natural order
(certain Christian denominations)
Others see it as an extension of medical progress and human ingenuity
(some Buddhist and Hindu perspectives)
Indigenous communities express concerns about genetic modification of traditional crops
Importance of respecting diverse cultural values in global gene editing policies
Challenges in reconciling conflicting views in multicultural societies
Bioethical principles
Fundamental ethical principles guide decision-making in gene editing research
Computational molecular biologists must consider these principles when designing and conducting studies
Balancing competing ethical considerations often requires careful analysis and deliberation
Autonomy and informed consent
Respect for individual decision-making in genetic interventions
Challenges in obtaining informed consent for future generations in germline editing
Complexities of consent in pediatric gene editing cases
Need for comprehensive education on risks and benefits of gene editing procedures
Importance of protecting vulnerable populations from coercion or exploitation
Considerations of privacy and control over genetic information
Beneficence vs non-maleficence
Beneficence: obligation to act for the benefit of others
Potential to cure genetic diseases and alleviate suffering
Non-maleficence: principle of avoiding harm
Risks of and off-target effects
Balancing potential benefits against known and unknown risks
Challenges in assessing long-term impacts of genetic modifications
Ethical dilemmas when benefits and risks affect different individuals or generations
Importance of robust preclinical testing and careful clinical trial design
Justice in genetic interventions
Fair distribution of benefits and risks of gene editing technologies
Concerns about exacerbating existing social inequalities
Debates on prioritization of gene editing research and applications
(rare vs common diseases)
Ethical considerations in selecting traits for enhancement
Potential for discrimination based on genetic characteristics
Importance of inclusive decision-making processes in policy development
Balancing individual rights with societal interests in genetic interventions
Future implications
Advances in gene editing technologies raise profound questions about the future of humanity
Computational molecular biologists play crucial role in shaping this future through research and innovation
Ethical foresight essential for responsible development of gene editing applications
Designer babies controversy
Potential for selecting or enhancing specific traits in embryos
Computational molecular biologists must navigate complex legal landscape in research and applications
Intersection of law, ethics, and science shapes development of gene editing technologies
Intellectual property rights
Patent disputes over CRISPR and other gene editing technologies
Challenges in balancing innovation incentives with public access to vital technologies
Debates on patentability of genetically modified organisms and human genes
Implications of patent laws for research collaboration and commercialization
Open-source movements in gene editing tools and databases
International differences in intellectual property regimes affecting global research
Liability for genetic modifications
Questions of legal responsibility for unintended consequences of gene editing
Potential for malpractice claims in clinical applications of gene therapy
Product liability issues for genetically modified organisms in agriculture
Challenges in establishing causation for long-term effects of genetic modifications
Debates on appropriate compensation mechanisms for gene editing harms
Need for legal frameworks to address novel situations arising from gene editing technologies
Privacy of genetic information
Legal protections for individual genetic data (GINA in the United States)
Challenges in maintaining anonymity with advancing genomic technologies
Debates on ownership and control of genetic information
Implications for insurance, employment, and personal relationships
Balancing research needs with individual privacy rights
International differences in genetic privacy laws and data sharing regulations
Ethical and legal issues in genetic testing of minors and prenatal genetic screening
Ethical decision-making
Integrating ethical considerations into gene editing research and applications requires structured approaches
Computational molecular biologists must develop skills in ethical analysis and decision-making
Importance of collaborative and transparent processes in addressing ethical challenges
Risk-benefit analysis
Systematic evaluation of potential positive and negative outcomes of gene editing interventions
Challenges in quantifying and comparing diverse types of risks and benefits
Consideration of short-term vs long-term consequences
Importance of addressing uncertainties and knowledge gaps in analysis
Use of decision trees and probabilistic models to aid in assessment
Ethical implications of how risks and benefits are defined and measured
Need for ongoing reassessment as new information becomes available
Stakeholder involvement
Identification and engagement of diverse stakeholders in gene editing decisions
(patients, families, researchers, clinicians, policymakers, general public)
Importance of including perspectives from marginalized or underrepresented groups
Challenges in balancing competing interests and values of different stakeholders
Use of deliberative democracy approaches in policy-making
Role of patient advocacy groups in shaping research priorities
Ethical considerations in managing conflicts of interest among stakeholders
Importance of transparency in stakeholder consultation processes
Ethical review processes
Institutional Review Boards (IRBs) for human subjects research
Animal Care and Use Committees for gene editing in animal models
National ethics committees for policy guidance on emerging technologies
International bodies providing ethical oversight for global research initiatives
Importance of interdisciplinary expertise in ethical review panels
Challenges in keeping pace with rapid advancements in gene editing technologies
Need for ongoing ethics education and training for researchers and review board members
Balancing thorough ethical scrutiny with timely advancement of beneficial research
Key Terms to Review (42)
ASC Guidelines: ASC guidelines refer to the ethical and safety standards set by the American Society of Gene and Cell Therapy for the responsible use of gene editing technologies. These guidelines emphasize the importance of safety, efficacy, and ethical considerations in research and clinical applications of gene editing, ensuring that scientific advancements do not compromise human rights or environmental integrity.
Beneficence vs Non-Maleficence: Beneficence refers to the ethical principle of acting in the best interest of others, promoting good and preventing harm. In contrast, non-maleficence focuses on the obligation not to inflict harm intentionally. These two principles are particularly important in discussions about ethical implications of gene editing, as they guide decision-making regarding the benefits and risks associated with manipulating genetic material.
Bioethics: Bioethics is the study of ethical issues emerging from advances in biology and medicine, focusing on the moral implications of biological research and applications. This field examines the responsibilities and ethical considerations that arise in various areas such as genetic engineering, clinical practices, and healthcare policies. As biotechnology progresses, bioethics becomes increasingly important in guiding decision-making processes and ensuring that scientific advancements align with societal values.
Biological determinism: Biological determinism is the belief that human behavior and characteristics are primarily shaped by genetic or biological factors. This perspective suggests that individuals' traits, including intelligence, personality, and even social behaviors, are largely predetermined by their DNA, downplaying the role of environment and experience in shaping who we are. The implications of this belief become particularly significant when discussing gene editing, as it raises questions about the ethical limits and potential consequences of manipulating genes to influence human traits.
Care ethics perspective: The care ethics perspective is a moral theory that emphasizes the importance of interpersonal relationships and the responsibilities that arise from them. It advocates for compassion, empathy, and the recognition of the interconnectedness of individuals within society. This approach contrasts with traditional ethical theories that prioritize abstract principles or rules, focusing instead on the nuances of context and the well-being of others.
Cartagena Protocol on Biosafety: The Cartagena Protocol on Biosafety is an international treaty aimed at ensuring the safe handling, transfer, and use of living modified organisms (LMOs) resulting from modern biotechnology. This protocol connects to the ethical implications of gene editing by establishing guidelines that govern how these organisms are assessed and managed, promoting transparency and risk assessment in biotechnological advancements to protect human health and the environment.
Consequentialism vs Deontology: Consequentialism and deontology are two major ethical theories that guide moral decision-making. Consequentialism focuses on the outcomes or consequences of actions to determine their morality, while deontology emphasizes the intrinsic rightness or wrongness of actions based on rules and duties, regardless of the outcomes. In discussions about gene editing, these ethical frameworks help evaluate the implications of altering genetic material in humans and other organisms.
CRISPR-Cas9: CRISPR-Cas9 is a revolutionary genome-editing tool derived from a natural defense mechanism in bacteria, allowing for precise alterations to DNA sequences. This technology uses a guide RNA to target specific DNA sequences and the Cas9 enzyme to cut the DNA, facilitating the removal or insertion of genetic material. Its applications in gene editing raise important considerations regarding mutations, DNA repair mechanisms, and the ethical implications surrounding its use in living organisms.
Deontological ethics: Deontological ethics is a moral philosophy that focuses on the inherent rightness or wrongness of actions, rather than their consequences. This approach emphasizes duties and rules, arguing that certain actions are morally obligatory, regardless of the outcomes they produce. In the context of gene editing, deontological ethics raises important questions about the moral implications of altering genes and the responsibilities that come with such powerful technologies.
Designer babies: Designer babies refer to infants whose genetic characteristics have been intentionally modified or selected through advanced genetic engineering techniques, such as CRISPR. This process aims to eliminate genetic disorders or enhance certain traits, like intelligence or physical appearance, raising complex ethical questions about human genetics and the implications of 'playing God' in reproduction.
Designer babies controversy: The designer babies controversy revolves around the ethical, social, and scientific debates surrounding the use of genetic engineering technologies, such as CRISPR, to select or modify traits in embryos. This raises questions about the implications of allowing parents to choose specific characteristics for their children, including physical appearance, intelligence, and health traits, potentially leading to a societal divide based on genetic enhancements.
Ethical review processes: Ethical review processes are systematic evaluations that assess the ethical implications of research involving human subjects, animals, or sensitive data. These processes aim to ensure that research is conducted with respect for participants' rights, welfare, and dignity while balancing scientific advancement. The importance of ethical review is magnified in areas like gene editing, where the potential consequences on individuals and society are profound and complex.
Gene drive: A gene drive is a genetic engineering technology that promotes the inheritance of a particular gene to increase its prevalence in a population. This mechanism allows a modified gene to be passed on to nearly all offspring, rather than the typical 50% expected from traditional inheritance, which can have profound impacts on population dynamics and species characteristics.
Genetic diversity concerns: Genetic diversity concerns refer to the issues and implications related to the variation of genes within a population, particularly in the context of conservation and the potential effects of gene editing technologies. High genetic diversity is crucial for a population's adaptability, survival, and resilience against diseases, while low genetic diversity can lead to inbreeding and increased vulnerability. As gene editing advances, these concerns grow, especially regarding how such technology may impact existing genetic diversity and ecological balance.
Genetic privacy: Genetic privacy refers to the protection of an individual's genetic information from unauthorized access, use, or disclosure. This concept is crucial as it intersects with informed consent in genomic research, ownership of genetic information, and the ethical implications surrounding gene editing. The sensitive nature of genetic data means that individuals should have control over who can access their genetic information and how it can be used, ensuring that their privacy is respected in various scientific and medical contexts.
George Church: George Church is a prominent American geneticist, molecular engineer, and biochemist known for his pioneering work in the fields of genetics and synthetic biology. He has significantly contributed to the development of gene editing technologies, particularly CRISPR, and has been a vocal advocate for the ethical considerations surrounding gene editing and its potential implications for society.
Germline modification: Germline modification refers to the genetic alteration of the germ cells (sperm and eggs) in an organism, which can lead to heritable changes that are passed down to future generations. This type of gene editing raises significant concerns about potential long-term effects on human evolution, ethical considerations surrounding 'designer babies', and the unpredictability of genetic consequences across generations.
Germline modifications: Germline modifications refer to genetic alterations made to the reproductive cells (sperm and eggs) that can be passed on to future generations. This type of gene editing holds significant potential for preventing hereditary diseases and enhancing specific traits in offspring, but it also raises complex ethical questions regarding its long-term implications on human evolution and societal norms.
Human Research Ethics Committees (HRECs): Human Research Ethics Committees (HRECs) are groups that review research proposals involving human participants to ensure ethical standards are maintained. They play a crucial role in safeguarding the rights and welfare of individuals participating in research, particularly in sensitive areas like gene editing, where ethical implications can be profound and complex.
Informed consent: Informed consent is the process through which individuals are provided with comprehensive information about a medical procedure or research study, enabling them to make knowledgeable decisions regarding their participation. This process emphasizes the importance of transparency, understanding potential risks and benefits, and respecting individuals' autonomy in decision-making. It is essential in various contexts, especially when dealing with sensitive data, genetic information, and the ethical implications of new technologies.
Institutional Review Boards (IRBs): Institutional Review Boards (IRBs) are committees established to review and oversee research involving human subjects, ensuring that the rights, welfare, and safety of participants are protected. These boards play a crucial role in evaluating the ethical implications of studies, particularly in sensitive areas such as gene editing, where the potential for significant impact on human genetics raises important ethical questions. By providing oversight, IRBs help maintain ethical standards and ensure compliance with regulations governing research practices.
Intellectual property rights: Intellectual property rights are legal protections granted to creators and inventors for their inventions, designs, and artistic works. These rights enable individuals to control and profit from their creations while promoting innovation and creativity in society. In the context of genetic information and gene editing, these rights raise complex questions regarding ownership, access, and ethical considerations surrounding the manipulation of genetic material.
Jennifer Doudna: Jennifer Doudna is an American biochemist known for her pioneering work in the field of gene editing, particularly in the development of the CRISPR-Cas9 technology. This revolutionary tool allows scientists to make precise changes to DNA, raising important questions about the ethical implications and potential consequences of editing the genomes of living organisms.
Justice in genetic interventions: Justice in genetic interventions refers to the ethical principle that seeks fairness and equity in the access, application, and implications of genetic technologies. This concept emphasizes that all individuals should have equal opportunity to benefit from advancements in genetic editing while also addressing potential disparities caused by socioeconomic status, race, or geography. It raises critical questions about who gets access to these technologies and how they may impact various populations differently.
Liability for genetic modifications: Liability for genetic modifications refers to the legal and ethical responsibility that arises from the use of gene editing technologies, particularly concerning the potential consequences and risks associated with altering an organism's genetic material. This concept encompasses issues such as accountability for unintended effects, the impact on biodiversity, and the moral implications of 'playing God' in manipulating life forms. As advancements in gene editing continue to unfold, these liabilities become increasingly significant, necessitating careful consideration of regulations and guidelines governing their application.
Nih guidelines: NIH guidelines refer to the regulations and policies set forth by the National Institutes of Health for conducting research involving human subjects and animals, ensuring ethical standards and scientific integrity. These guidelines play a crucial role in the oversight of gene editing research, emphasizing safety, ethical considerations, and respect for individuals' rights.
Off-target effects: Off-target effects refer to unintended changes in the genome that occur when gene editing tools, like CRISPR, interact with sites other than the intended target. These effects can lead to mutations or alterations that may have unknown consequences on the organism's health and functionality. Understanding off-target effects is critical when considering the safety and ethical implications of gene editing, as they can raise concerns about potential risks associated with altering an organism's genetic material.
Potential for species alteration: The potential for species alteration refers to the capacity of gene editing technologies, such as CRISPR, to modify the genetic makeup of living organisms, thereby influencing their characteristics, behaviors, and interactions with ecosystems. This capability raises significant ethical considerations about the consequences of altering species, including potential impacts on biodiversity, ecological balance, and the unforeseen effects on both natural and human-managed environments.
Privacy of genetic information: Privacy of genetic information refers to the ethical and legal considerations surrounding the handling, sharing, and protection of individuals' genetic data. This concept is critical in the context of gene editing because advances in genetic technologies raise questions about who has access to genetic information, how it can be used, and the potential for misuse or discrimination based on genetic traits.
Public Engagement: Public engagement refers to the process of involving the public in decision-making, discussions, and actions that relate to societal issues. It emphasizes collaboration between scientists, policymakers, and the general public to foster understanding, build trust, and ensure that diverse perspectives are considered, especially concerning advancements like gene editing. This interaction is crucial in addressing ethical implications and informing policy related to emerging biotechnologies.
Regulatory compliance: Regulatory compliance refers to the process of ensuring that an organization adheres to the laws, regulations, guidelines, and specifications relevant to its business processes. In the context of genetic research and gene editing, regulatory compliance involves navigating a complex framework of ethical standards and legal requirements that govern the use of these technologies to ensure safety, efficacy, and ethical integrity.
Research ethics committees (RECs): Research ethics committees (RECs) are independent groups that review research proposals to ensure they comply with ethical standards, protecting the rights, safety, and well-being of research participants. They evaluate whether the benefits of a study outweigh the risks and ensure informed consent processes are in place. This oversight is especially critical in fields like gene editing, where ethical dilemmas can arise from the manipulation of genetic material.
Risk assessment: Risk assessment is the process of identifying, evaluating, and prioritizing potential risks that could negatively impact individuals, communities, or environments, especially in the context of new technologies and practices. This process is crucial in determining the ethical implications of innovations like gene editing, as it helps to weigh the benefits against potential harms and ensure informed decision-making in scientific advancements.
Risk-benefit analysis: Risk-benefit analysis is a systematic process for evaluating the potential risks and benefits associated with a particular action or decision, especially in the fields of medicine and research. It helps in determining whether the potential benefits justify the risks involved, ensuring that participants are not unduly exposed to harm. In the context of genomic research and gene editing, this analysis is crucial for making informed ethical decisions about how to proceed while considering the implications for individuals and society as a whole.
Social Equity: Social equity refers to the fair and just treatment of individuals and groups, ensuring that everyone has access to the same opportunities and resources. It emphasizes the need to address and rectify disparities that arise from historical and systemic inequalities, promoting inclusivity and equality across various social dimensions. In the context of gene editing, social equity raises questions about who benefits from advancements in technology and how these benefits can be equitably distributed among all societal segments.
Somatic modifications: Somatic modifications refer to changes made to the non-reproductive cells of an organism, affecting traits without altering the germline DNA that is passed to offspring. These alterations can result from various processes, such as gene editing or environmental influences, and can have significant implications for an individual's health and biological functions. Since somatic modifications do not affect germ cells, they raise ethical questions about the permanence and consequences of these changes in living organisms.
Stakeholder involvement: Stakeholder involvement refers to the process of engaging individuals or groups who have an interest in or are affected by a particular project or decision. This concept is crucial because it ensures that diverse perspectives are considered, leading to more informed and ethical outcomes, especially in areas like gene editing where implications can affect society at large.
UNESCO Universal Declaration on the Human Genome and Human Rights: The UNESCO Universal Declaration on the Human Genome and Human Rights is a document adopted in 1997 that emphasizes the inherent dignity and rights of individuals in relation to their genetic information. It underscores the importance of safeguarding human rights while advancing genomic research, ensuring that genetic information is not misused and that individuals retain control over their genetic data. This declaration is essential in guiding discussions on ownership of genetic information and the ethical implications associated with gene editing.
Unintended Consequences: Unintended consequences refer to outcomes that are not the ones foreseen or intended by a purposeful action. In the context of gene editing, these can arise from modifications made to an organism's genetic material, leading to unexpected effects that may impact not only the modified organism but also ecosystems and human health.
Utilitarianism: Utilitarianism is an ethical theory that proposes that the best action is the one that maximizes overall happiness or utility. This philosophy often weighs the consequences of actions to determine their moral value, aiming for the greatest good for the greatest number of people. In the context of gene editing, utilitarianism raises important questions about the balance between potential benefits and risks associated with genetic modifications.
Virtue ethics approach: The virtue ethics approach is a moral philosophy that emphasizes the role of character and virtues in ethical decision-making, rather than focusing solely on rules or consequences. This approach suggests that the development of good character traits, or virtues, such as honesty, courage, and compassion, leads individuals to make better ethical choices. In the context of gene editing, this approach raises questions about what kind of individuals we should aspire to be and how our choices reflect our values.
WHO Expert Advisory Committee on Human Genome Editing: The WHO Expert Advisory Committee on Human Genome Editing is a specialized group formed by the World Health Organization to provide guidance and recommendations regarding the ethical, scientific, and social implications of human genome editing technologies. The committee aims to establish global standards and frameworks to ensure that the application of gene editing is conducted responsibly, taking into account potential risks and benefits.